Considering personalized Interferon-β therapy for COVID-19
Résumé
Davoudi-Monfared et al. (1) report in this Journal the results from a clinical trial on COVID-19 patients showing that subcutaneous administration of interferon-β (IFN-β) was associated with a more rapid recovery from SARS-CoV-2 infection and decreased mortality.….
Domaines
Sciences du Vivant [q-bio]
Fichier principal
Antimicrobial Agents and Chemotherapy-2021-Dorgham-AAC.00065-21.full.pdf (524.65 Ko)
Télécharger le fichier
Origine : Publication financée par une institution